bluebird bio (BLUE)
(Delayed Data from NSDQ)
$0.53 USD
-0.04 (-7.00%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $0.53 0.00 (0.21%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Cash flow Statements
Fiscal Year End for bluebird bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -266.58 | -819.38 | -618.70 | -789.61 |
Depreciation/Amortization & Depletion | NA | 5.00 | 19.65 | 19.36 | 17.43 |
Net Change from Assets/Liabilities | NA | -81.83 | 17.99 | -42.73 | 29.36 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | -9.55 | 146.11 | 171.72 | 178.43 |
Net Cash From Operating Activities | NA | -352.95 | -635.64 | -470.35 | -564.38 |
Property & Equipment | NA | -8.21 | -14.50 | -28.99 | -71.03 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 161.66 | 585.56 | -55.36 | 584.06 |
Other Investing Activities | NA | 97.00 | -8.50 | 0.00 | -5.22 |
Net Cash from Investing Activities | NA | 250.45 | 562.56 | -84.35 | 507.81 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 54.25 | 80.33 | 546.72 | 21.19 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | -174.28 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 54.25 | -93.95 | 546.72 | 21.19 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -48.25 | -167.04 | -7.98 | -35.39 |
Cash at Beginning of Period | NA | 206.69 | 373.73 | 381.71 | 417.10 |
Cash at End of Period | NA | 158.45 | 206.69 | 373.73 | 381.71 |
Diluted Net EPS | NA | -3.39 | -11.89 | -9.95 | -14.31 |
Fiscal Year End for bluebird bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | NA | NA | -123.40 | -51.67 |
Depreciation/Amortization & Depletion | NA | NA | NA | 3.12 | 2.05 |
Net Change from Assets/Liabilities | NA | NA | NA | -29.37 | -56.35 |
Net Cash from Discontinued Operations | NA | NA | NA | 0.00 | 0.00 |
Other Operating Activities | NA | NA | NA | -71.57 | -53.40 |
Net Cash From Operating Activities | NA | NA | NA | -221.21 | -159.36 |
Property & Equipment | NA | NA | NA | -2.98 | -0.94 |
Acquisition/ Disposition of Subsidiaries | NA | NA | NA | 0.00 | 0.00 |
Investments | NA | NA | NA | 62.08 | -2.04 |
Other Investing Activities | NA | NA | NA | 92.06 | 92.06 |
Net Cash from Investing Activities | NA | NA | NA | 151.16 | 89.08 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | NA | NA | 129.97 | 130.01 |
Issuance (Repayment) of Debt | NA | NA | NA | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | NA | NA | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | NA | NA | 0.00 | 0.00 |
Other Financing Activities | NA | NA | NA | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | NA | NA | 129.97 | 130.01 |
Effect of Exchange Rate Changes | NA | NA | NA | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | NA | NA | 59.92 | 59.73 |
Cash at Beginning of Period | NA | NA | NA | 158.45 | 158.45 |
Cash at End of Period | NA | NA | NA | 218.37 | 218.17 |
Diluted Net EPS | NA | NA | NA | -0.66 | -0.67 |